PTP1B can directly interact with the insulin receptor [87] and insulin receptor substrate 1 (IRS-1) [88], dephosphorylating the tyrosine residues in the activation loops of these molecules to down-regulate insulin signaling, thereby contributing to an insulin resistance phenotype in T2DM patients. Here, INS is linked to Insulin resistance.